HGH Fragment 176-191

Also known as: hGH 176-191 · Somatotropin fragment 176-191

Preclinical evidence

Grade describes the published research on the molecule. It is not a quality score, a safety score, or a release state.

What this is

HGH Fragment 176-191 reproduces the final 16 residues of human growth hormone. AOD-9604 is a different 16-residue analog: it uses tyrosine followed by hGH residues 177-191.

Evidence position

The exact fragment has a small direct laboratory record. Grade C does not borrow the larger preclinical or human-development record attached to AOD-9604.

What the record does not establish

A shared 15-residue core does not make the two compounds interchangeable. Sequence, disulfide state, salt form and lot-level analytical results must match the named material.

Sources

01
HGH Fragment 176-191 compound recordPubChem
Shows
Chemical registry record for the HGH 176-191 material
Does not show
An identity record does not establish biological effects or a supplier lot
02
HGH Fragment 176-191 with doxorubicin nanoparticles in breast-cancer cellsPubMed
Shows
Direct in-vitro experiment using HGH Fragment 176-191
Does not show
Cell and nanoparticle study; no human outcome evidence
03
AOD9604 detection and in-vitro metabolismPubMed
Shows
Defines AOD-9604 as hGH 177-191 with an added N-terminal tyrosine
Does not show
Identity comparison only; AOD-9604 evidence is not fragment 176-191 evidence

External database index

LIVE DATABASE INDEX / SEPARATE FROM CURATED EVIDENCE

Records below come directly from public scientific databases. They help find relevant material, but do not affect the evidence grade until they are matched to the molecule and added to the curated source list.

PUBCHEM / IDENTITY